EBRT in Hepatocellular Carcinoma: Multinational Data Support Its Role in Early-Stage Disease

UICC's 2025 Annual Report is Now Available

ACT 4 Children and Partners Establish a "Home Away from Home" for Pediatric Oncology Families

Adjuvant Radiotherapy After Radical Cystectomy in High-Risk Muscle-Invasive Bladder Cancer

Grand Rounds by OncoDaily: AI in Oncology Edition

Oncology News, Insights, Stories by OncoDaily

Yvonne-Awards-2026 - OncoDaily
OncoDaily

Yvonne Awards 2026

CROWN study
Voices

Oncologist Perspectives on the CROWN Study - Lorlatinib in Stage III ALK-Positive NSCLC

Sarcoma
OncoDaily Pulse

OncoDaily Brings Sarcoma Experts Together at ASCO 2026

Cristiane D Bergerot: ASCO26 Must-Read Abstracts

Muna Al-Khaifi: Managing Low Sexual Drive in Cancer Survivors - What the Latest Evidence Shows

NIVOTAX Trial: Paclitaxel Plus Nivolumab in Cisplatin-Ineligible Head and Neck Cancer

Zainab Shinkafi-Bagudu: Commonwealth Leaders Advance Cervical Cancer Elimination in Geneva

Dato-DXd Plus Durvalumab Shows Durable First-Line Activity in Advanced TNBC

The GI Cancers Alliance is Growing

Fabio Ynoe de Moraes: A Rejection is Not Always a Verdict on Quality

Voices
Yan Leyfman

Yan Leyfman: AI is Now Helping Redesign the Molecular Machinery Behind Genome Editing Itself

Erika Hamilton: So Important to Really Understand Clinical Trials Before You Get Diagnosed With Cancer

Lucjan Wyrwicz: Have You Voted in ESMO Presidential Elections?

Alique Topalian: Global Collaboration Advancing Survivorship Research in Primary Care

Lisa Stevens: Discussions on NCCPs Were Prevalent During WHA - What's Next?

Initially Withdrawn, Sanu Gradually Began to Connect With Others Via Music, Games, and Laughter – WCC

Sami Mansfield: Powerful Voices Disrupting Cancer Care Through Bold Leadership

FDA Approvals
FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

Aktis Advances Radiopharmaceutical Pipeline With AKY-2519 FDA Clearance

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

NCCN Webinar - Hepatocellular Carcinoma: Latest Systemic Therapy Recommendations

National Comprehensive Cancer Network (NCCN)

28 May
Hepatocellular Carcinoma

BTOG (British Thoracic Oncology Group) National Trials Meeting 2026

British Thoracic Oncology Group

22 Jul
British Thoracic Oncology Group

SPCC (Sharing Progress in Cancer Care) Webinar - HER2DX: Translating Biology into Care

Sharing Progress in Cancer Care

16 Jun
SPCC

MASCC Webinar: The Role of Biosimilars in Expanding Access and Sustainability

MASCC

11 Jun
MASCC

ASCO 2026: Key Highlights for Stomach/Gastric Cancer Patients

GI Cancers Alliance

09 Jun
ASCO 2026: Key Highlights for Stomach/Gastric Cancer Patients

Immune-oncology
NIVOTAX Trial: Paclitaxel Plus Nivolumab in Cisplatin-Ineligible Head and Neck Cancer

NIVOTAX Trial: Paclitaxel Plus Nivolumab in Cisplatin-Ineligible Head and Neck Cancer

Polish–Czech Real-World Analysis of Cemiplimab Immune Toxicities in Cervical Cancer

Asthma Drug Enhances Immunotherapy Response in Resistant Cancers

Camrelizumab Plus Apatinib in Refractory Chordoma: A Phase II Clinical Trial

Immunophenotypic Signatures Predict Immunotherapy Response and Survival in NSCLC

Short-Term Fasting Enhances Immunotherapy Response

CheckMate 73L: Nivolumab Plus Chemoradiotherapy for Stage III NSCLC

Gastrointestinal-Oncology
EBRT in HCC

EBRT in Hepatocellular Carcinoma: Multinational Data Support Its Role in Early-Stage Disease

Breaking the Undruggable: KRAS G12D Inhibition and the Emerging Era of Precision Oncology in PDAC

IMbrave050 Updates: Adjuvant Atezolizumab Plus Bevacizumab in High-Risk HCC

Top Colorectal Cancer Trials to Watch at ASCO 2026

10 Must-Read Posts In GI Oncology This Week

POD1UM-303/InterAACT-2 Trial: Retifanlimab plus Chemo in 1L Advanced Squamous Anal Cancer

Sintilimab Plus Lenvatinib Followed by Surgery in Unresectable HCC

Breast-Oncology
Dato-DXd Plus Durvalumab

Dato-DXd Plus Durvalumab Shows Durable First-Line Activity in Advanced TNBC

NeoTRIPaPDL1 Transcriptomic Analysis Reveals Early Predictors of Response in TNBC

TQB2102 Shows Early Activity Across HER2-Expressing Solid Tumors

OLIGOMA Trial: SBRT Extends PFS in Oligometastatic Breast Cancer

Chest Wall Perforator Flaps in Breast Cancer Surgery: What the Evidence Shows So Far

FDA Approves T-DXd for Two Early HER2-Positive Breast Cancer Settings

Metastatic Breast Cancer: Liquid Biopsy Reveals an Immunovascular Signature

Lung-Oncology
Henlius

Henlius Advances HLX43 Phase 2 Trial in NSCLC With First EU Patient Dosed

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

PD-(L)1 Blockade in Never-Smokers With AGA-Negative NSCLC: What the Data Show

Tumor-Naïve ctDNA Testing May Refine Risk in Early-Stage NSCLC

Second-Event Endpoints After Anti–PD-(L)1 Therapy: Are We Measuring Immunotherapy Benefit the Right Way?

T-DXd Plus Sotorasib Shows Preclinical Promise in KRAS G12C-Mutant NSCLC

5 Powerful Findings on Pembrolizumab Dosing in NSCLC

OncoDaily TV
How Desmond Yip Helped Build Cancer Care in the Solomon Islands

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Annalice Gandini

GI News Updates with Annalice Gandini

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Hisham Mehanna

What It Takes to Lead in Oncology Prof. Hisham Mehanna on Research, Mentorship & Life Balance

ASCO

ASCO 2026 with OncoDaily: Yvonne Awards, AI in Oncology, Grand Rounds and Live Coverage from Chicago

Lucica Ditiu

Ending Tuberculosis by 2030: Is It Still Possible? | Dr Lucica Ditiu

City-Level Cancer Care: A Missing Piece in the Puzzle?

City-Level Cancer Care: A Missing Piece in the Puzzle?

Empowering Oncologists: Why Survivorship Matters?

Empowering Oncologists: Why Survivorship Matters?

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Fixing the Broken Link Between Patients and Cancer Care in Developing Countries: Dr. Emad Shash

Fixing the Broken Link Between Patients and Cancer Care in Developing Countries: Dr. Emad Shash

Not To Miss
WHA79 - OncoDaily

25 Posts Not To Miss From WHA79

Highlights From How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

20 Posts Not To Miss From AUA26: American Urological Association Annual Meeting

King Hussein Cancer Research Award: Advancing Cancer Research Across the Arab World 2026

10 Must-Read Posts In GU Oncology This Week

10 Must-Read Posts In GI Oncology This Week

15 Posts Not To Miss From RomeLung26

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
CLL-RT

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

CancerWorld

Oncologists
Jyoti Malhotra

Jyoti Malhotra

Oncologists Location Duarte, USA
Alexandra Müller

Alexandra Müller

Oncologists Location Freiburg, Germany
Hagop-Kantarjian

Hagop Kantarjian

Oncologists Location Houston, USA
Dilyara Kaidarova

Dilyara Kaidarova

Oncologists Location Almaty, Kazakhstan
Katherine Van Loon

Katherine Van Loon

Oncologists Location San Francisco, USA
Jay M. Lee

Jay M. Lee

Oncologists Location Los Angeles, USA
Luiz H. de Lima Araujo

Luiz H. de Lima Araujo

Oncologists Location Rio de Janeiro, Brazil
Jalid Sehouli

Jalid Sehouli

Oncologists Location Berlin, Germany

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

Drug Discovery

Human-Centric New Approach Methodologies in Drug Discovery

PROOF 301

PROOF 301 Trial: Infigratinib vs Gemcitabine/Cisplatin in FGFR2-Rearranged Cholangiocarcinoma

OncoDaily Medical Journal

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research